Overview

A Study to Assess the Effects of Repeat Doses of Fluticasone Furoate and GW642444M Combination in Healthy Subjects and in Subjects With Severe Impairment.

Status:
Completed

Trial end date:
2011-03-22

Target enrollment:

Participant gender:

Summary

This study will assess the saftey of giving fluticasone furoate 200mcg/GW642444M 25mcg once daily for 7 days to patients with severe renal imparement. The results of this study will aid in deciding whether a FF/GW642444M doseadjustment is justified in subjects with severe renal impairment and in estimating any such adjustments.

Phase:

Phase 1

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Fluticasone